Source: Cancer Gene Therapy. Unidades: IB, FMRP
Subjects: ASTROCITOMA, PROTEÍNAS QUINASES, CICLO CELULAR, INIBIDORES DE ENZIMAS
ABNT
PEZUK, J. A. et al. Polo-like kinase 1 inhibition causes decreased proliferation by cell cycle arrest, leading to cell death in glioblastoma. Cancer Gene Therapy, v. 20, n. 9, p. 499-506, 2013Tradução . . Disponível em: https://doi.org/10.1038/cgt.2013.46. Acesso em: 30 ago. 2024.APA
Pezuk, J. A., Brassesco, M. S., Morales, A. G., Oliveira, J. C. de, Queiroz, R. G. de P., Machado, H. R., et al. (2013). Polo-like kinase 1 inhibition causes decreased proliferation by cell cycle arrest, leading to cell death in glioblastoma. Cancer Gene Therapy, 20( 9), 499-506. doi:10.1038/cgt.2013.46NLM
Pezuk JA, Brassesco MS, Morales AG, Oliveira JC de, Queiroz RG de P, Machado HR, Carlotti Júnior CG, Serafini LN, Scrideli CA, Tone LG. Polo-like kinase 1 inhibition causes decreased proliferation by cell cycle arrest, leading to cell death in glioblastoma [Internet]. Cancer Gene Therapy. 2013 ; 20( 9): 499-506.[citado 2024 ago. 30 ] Available from: https://doi.org/10.1038/cgt.2013.46Vancouver
Pezuk JA, Brassesco MS, Morales AG, Oliveira JC de, Queiroz RG de P, Machado HR, Carlotti Júnior CG, Serafini LN, Scrideli CA, Tone LG. Polo-like kinase 1 inhibition causes decreased proliferation by cell cycle arrest, leading to cell death in glioblastoma [Internet]. Cancer Gene Therapy. 2013 ; 20( 9): 499-506.[citado 2024 ago. 30 ] Available from: https://doi.org/10.1038/cgt.2013.46